<h4>Purpose</h4>This manuscript explores the potential of dual glucagon-like peptide 1 (GLP-1) agonists combined with degludec basal insulin as a treatment approach for early type 1 diabetes. The gene discussed is GCG; the disease is type 1 diabetes mellitus.